/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Recombinant Interleukin-1 receptor antagonist for the treatment of ST-segment elevation acute myocardial infarction prevents future heart failure events: a pooled analysis of the VCUART program
Event: ESC Congress 2020
Topic: Pharmacotherapy
Session: Acute Coronary Syndromes ePosters
Predictive role of C-reactive protein levels in patients with ST-segment elevation acute myocardial infarction for heart failure related events
Event: ESC Congress 2019
Topic: Prevention
Session: Is inflammation really important in heart failure?
Effects of Interleukin-1 blockade with anakinra in patients with ST-segment elevation acute myocardial infarction on recurrent ischemic events: results from the VCUART3 study
Event: ESC Congress 2019
Topic: Pharmacotherapy
Session: Inflammation
Interleukin-1 blockade in recently decompensated systolic heart failure: the recently decompensated heart failure anakinra response trial (REDHART)
Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure
Topic: Acute heart failure (management)
Session: Moderated Poster session 5 - Tips and tricks to prevent readmissions
ESC 365 is supported by
